research use only

CD62L/L-Selectin Antibody [H14P17]

Cat.No.: F4755

    Application: Reactivity:

    Usage Information

    Dilution
    1:1000
    1:150 - 1:600
    Application
    WB, IHC
    Reactivity
    Mouse
    Source
    Rabbit Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    60-100 kDa
    Positive Control GL261 syngeneic tumor; Mouse thymus; LL/2 syngeneic tumor; CT26 syngeneic tumor; Mouse spleen; Mouse small intestine; Mouse lung; Mouse CD8+ T cells; EL4 cells; BA/F3 cells
    Negative Control Neuro-2a cells

    Datasheet & SDS

    Biological Description

    Specificity
    CD62L/L-Selectin Antibody [H14P17] detects endogenous levels of total CD62L/L-Selectin protein.
    Clone
    H14P17
    Synonym(s)
    L-selectin; CD62 antigen-like family member L; Leukocyte adhesion molecule 1 (LAM-1); LECAM1; Lymphocyte antigen 22; lY-22; Lymphocyte surface MEL-14 antigen; CD62L; Sell; Lnhr; Ly-22; Ly22
    Background
    CD62L (L-Selectin, SELL) is a type-I transmembrane glycoprotein belonging to the selectin family of cell adhesion molecules (alongside E- and P-selectin), expressed on most circulating leukocytes including naive T cells, central memory T cells, monocytes, and neutrophils, where it mediates initial tethering and rolling on high endothelial venules (HEVs) in lymphoid tissues via weak calcium-dependent bonds with sulfated O-linked glycans on GlyCAM-1, CD34, and MAdCAM-1. It comprises an N-terminal C-type lectin domain for ligand carbohydrate recognition (key residues like Ca²⁺-coordinating Asp/Asp/Glu in epidermal growth factor-like domain), a single EGF-like domain, two consensus repeats for rigidity, a highly basic 17-residue cytoplasmic tail interacting with ERM proteins (ezrin-radixin-moesin), calmodulin, and PKC for cytoskeletal linkage and signaling, and a membrane-proximal extracellular stalk cleaved by ADAM17 protease during activation. Its primary functions involve facilitating lymphocyte homing to lymph nodes by enabling shear-resistant rolling on HEVs, promoting monocyte protrusion and transendothelial migration (TEM) through ERM-mediated actin remodeling, and signaling via Src kinases/FAK to enhance chemotaxis toward CCL21; post-activation shedding of CD62L is antigen-specific, downregulating HEV binding while enabling front-back polarity, cytotoxic granule mobilization (CD107a+), and perforin/granzyme release in effector T cells. CD62L distinguishes naive/central memory (CD62L^hi) from effector memory (CD62L^lo) T cells, regulates inflammation by balancing recruitment and emigration, and supports immune surveillance; shedding-resistant mutants impair lytic function by ~50%, linking ectodomain release to cytoskeleton reorganization. Dysregulated CD62L shedding contributes to chronic lymphocytic leukemia infiltration, excessive inflammation in atherosclerosis, and impaired antiviral immunity.
    References
    • https://pubmed.ncbi.nlm.nih.gov/31139190/
    • https://pubmed.ncbi.nlm.nih.gov/21829468/

    Tech Support

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3

    If you have any other enquiries, please leave a message.